Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Nutt

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Pharmacokinetics and pharmacodynamics of levodopaJohn G Nutt
Experimental Neurology|November 26, 2003
Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's diseaseJohn G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2013
Higher-level gait disorders: an open frontierJohn G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2006
Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?John G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|March 12, 2015
Continuous levodopa infusion is better—for nowJohn G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|May 27, 2016
Motor subtype in Parkinson's disease: Different disorders or different stages of disease?John G Nutt
Neurology|May 24, 2006
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirementsJohn G Nutt
European Journal of Clinical Pharmacology|December 20, 2007
Disease progression, drug action and Parkinson's disease: why time cannot be ignoredNick Holford, John G Nutt
The New England Journal of Medicine|September 9, 2005
Clinical practice. Diagnosis and initial management of Parkinson's diseaseJohn G Nutt, G Frederick Wooten
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 9, 2008
Treatment of Parkinson's disease with trophic factorsAmie L Peterson, John G Nutt
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Pharmacokinetics and pharmacodynamics of levodopaJohn G Nutt
Experimental Neurology|November 26, 2003
Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's diseaseJohn G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2013
Higher-level gait disorders: an open frontierJohn G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2006
Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?John G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|March 12, 2015
Continuous levodopa infusion is better—for nowJohn G Nutt
Movement Disorders : Official Journal of the Movement Disorder Society|May 27, 2016
Motor subtype in Parkinson's disease: Different disorders or different stages of disease?John G Nutt
Neurology|May 24, 2006
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirementsJohn G Nutt
European Journal of Clinical Pharmacology|December 20, 2007
Disease progression, drug action and Parkinson's disease: why time cannot be ignoredNick Holford, John G Nutt
The New England Journal of Medicine|September 9, 2005
Clinical practice. Diagnosis and initial management of Parkinson's diseaseJohn G Nutt, G Frederick Wooten
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 9, 2008
Treatment of Parkinson's disease with trophic factorsAmie L Peterson, John G Nutt
Pageof 15